Access cutting-edge primary open angle glaucoma treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access primary open angle glaucoma specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related primary open angle glaucoma treatment provided free
The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).
Sponsor: Amydis Inc.
Check if you qualify for this primary open angle glaucoma clinical trial in Phoenix, AZ
If you're searching for primary open angle glaucoma treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary open angle glaucoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.